Journal
LIVER CANCER
Volume 9, Issue 6, Pages 629-639Publisher
KARGER
DOI: 10.1159/000512170
Keywords
Immune checkpoint inhibitors; Atezolizumab; Bevacizumab; Combination immunotherapy